TP53 is a cell checkpoint protein that is commonly mutated and inactivated in HPV-negative HNSCC, occurring in 83% of cases, or degraded in HPV-positive HNSCC via the E6 oncogene [11,46]. Here, TP53 is linked to head and neck squamous cell carcinoma.